|
When used with the patient history and physical exam, ImmunoCAP
specific IgE blood testing provides objective, quantifiable evidence
of IgE-mediated allergen sensitivity to help the clinician diagnose
and manage common respiratory illnesses. This is important because
different etiologies require different treatments.1 Confirmed
knowledge of underlying atopic disease allows the incorporation
of avoidance measures and other allergy-based therapies (such
as non-sedating antihistamines or leukotriene antagonists).2,3 In
non-allergic disease, meanwhile, the clinician can consider
such medications as intranasal corticosteroids, antibiotics,
and decongestants.2
ImmunoCAP
makes it easy for primary care clinicians to perform
an allergy evaluation.2 Utilizing
pre-selected profiles of both seasonal and inhalant airborne allergens,
ImmunoCAP test results provide the clinician clear evidence to help
rule in or rule out the presence of atopy, identify and quantify
any specific allergic sensitivities, and guide effective management.
For more information of possible therapeutic strategies, visit the
section on disease
management. Here you can read about various options, including avoidance counseling, medication selection, immunotherapy,
and timely referral.
ImmunoCAP can be conducted on patients of any age, as young as 3
months, regardless of the medications they are already taking, and
only a single blood draw is required. Many laboratories
and reference laboratories offer ImmunoCAP.
|
